| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.
|
MBio
|
2012
|
8.54
|
|
2
|
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.
|
Lancet Infect Dis
|
2013
|
7.83
|
|
3
|
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
|
Nature
|
2013
|
6.39
|
|
4
|
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.
|
MBio
|
2012
|
3.96
|
|
5
|
Virology: SARS virus infection of cats and ferrets.
|
Nature
|
2003
|
3.86
|
|
6
|
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells.
|
Proc Natl Acad Sci U S A
|
2013
|
2.99
|
|
7
|
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
|
J Infect Dis
|
2006
|
2.55
|
|
8
|
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
|
Hepatology
|
2006
|
2.54
|
|
9
|
A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.
|
J Virol Methods
|
2003
|
1.96
|
|
10
|
Geographic distribution of MERS coronavirus among dromedary camels, Africa.
|
Emerg Infect Dis
|
2014
|
1.96
|
|
11
|
Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.
|
J Virol
|
2006
|
1.90
|
|
12
|
The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters.
|
PLoS One
|
2013
|
1.88
|
|
13
|
The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies.
|
J Virol
|
2013
|
1.81
|
|
14
|
Metagenomic analysis of the viral flora of pine marten and European badger feces.
|
J Virol
|
2011
|
1.79
|
|
15
|
Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes.
|
J Hepatol
|
2010
|
1.78
|
|
16
|
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.
|
Lancet
|
2004
|
1.70
|
|
17
|
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.
|
PLoS One
|
2011
|
1.69
|
|
18
|
Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014.
|
Emerg Infect Dis
|
2014
|
1.59
|
|
19
|
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.
|
AIDS
|
2011
|
1.50
|
|
20
|
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment.
|
J Gen Virol
|
2013
|
1.45
|
|
21
|
Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.
|
PLoS Pathog
|
2013
|
1.43
|
|
22
|
Novel hepatitis E virus in ferrets, the Netherlands.
|
Emerg Infect Dis
|
2012
|
1.38
|
|
23
|
Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.
|
J Virol
|
2013
|
1.37
|
|
24
|
Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice.
|
G3 (Bethesda)
|
2012
|
1.35
|
|
25
|
Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.
|
J Virol
|
2013
|
1.34
|
|
26
|
Comparative study of different methods to genotype hepatitis C virus type 6 variants.
|
J Virol Methods
|
2003
|
1.32
|
|
27
|
New viruses in idiopathic human diarrhea cases, the Netherlands.
|
Emerg Infect Dis
|
2014
|
1.32
|
|
28
|
Exacerbated innate host response to SARS-CoV in aged non-human primates.
|
PLoS Pathog
|
2010
|
1.26
|
|
29
|
Identification of multiple novel viruses, including a parvovirus and a hepevirus, in feces of red foxes.
|
J Virol
|
2013
|
1.20
|
|
30
|
Novel cyclovirus in human cerebrospinal fluid, Malawi, 2010-2011.
|
Emerg Infect Dis
|
2013
|
1.19
|
|
31
|
Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques.
|
PLoS Pathog
|
2007
|
1.16
|
|
32
|
Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients.
|
J Virol
|
2007
|
1.16
|
|
33
|
Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.
|
Gastroenterology
|
2006
|
1.10
|
|
34
|
Pathogenesis of Middle East respiratory syndrome coronavirus.
|
J Pathol
|
2015
|
1.10
|
|
35
|
Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions.
|
J Clin Microbiol
|
2006
|
1.09
|
|
36
|
Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014.
|
Emerg Infect Dis
|
2015
|
1.06
|
|
37
|
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
|
Gastroenterology
|
2007
|
1.06
|
|
38
|
DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
|
Virus Res
|
2008
|
1.05
|
|
39
|
Metagenomic analysis of the ferret fecal viral flora.
|
PLoS One
|
2013
|
1.02
|
|
40
|
The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain.
|
Virology
|
2003
|
1.00
|
|
41
|
Updated phylogenetic analysis of arenaviruses detected in boid snakes.
|
J Virol
|
2014
|
0.99
|
|
42
|
Complete genome analysis of hepatitis C virus subtypes 6t and 6u.
|
J Gen Virol
|
2008
|
0.97
|
|
43
|
Enteric coronavirus in ferrets, The Netherlands.
|
Emerg Infect Dis
|
2011
|
0.97
|
|
44
|
MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic.
|
Emerg Infect Dis
|
2016
|
0.97
|
|
45
|
Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
|
Southeast Asian J Trop Med Public Health
|
2002
|
0.96
|
|
46
|
Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.
|
J Virol
|
2013
|
0.96
|
|
47
|
Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics.
|
AIDS
|
2009
|
0.96
|
|
48
|
Spiking the MERS-coronavirus receptor.
|
Cell Res
|
2013
|
0.95
|
|
49
|
T-Cell tropism of simian varicella virus during primary infection.
|
PLoS Pathog
|
2013
|
0.92
|
|
50
|
Molecular epidemiology of gibbon hepatitis B virus transmission.
|
J Gen Virol
|
2003
|
0.88
|
|
51
|
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.
|
PLoS One
|
2011
|
0.88
|
|
52
|
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.
|
Hepatology
|
2006
|
0.86
|
|
53
|
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.
|
PLoS One
|
2013
|
0.86
|
|
54
|
Virogenomics: the virus-host interaction revisited.
|
Curr Opin Microbiol
|
2008
|
0.86
|
|
55
|
Deletion Variants of Middle East Respiratory Syndrome Coronavirus from Humans, Jordan, 2015.
|
Emerg Infect Dis
|
2016
|
0.86
|
|
56
|
Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.
|
J Virol
|
2002
|
0.86
|
|
57
|
Detection of Circovirus in Foxes with Meningoencephalitis, United Kingdom, 2009-2013.
|
Emerg Infect Dis
|
2015
|
0.85
|
|
58
|
Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus.
|
Emerg Infect Dis
|
2017
|
0.84
|
|
59
|
Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species.
|
J Virol
|
2011
|
0.84
|
|
60
|
Calicivirus from novel Recovirus genogroup in human diarrhea, Bangladesh.
|
Emerg Infect Dis
|
2012
|
0.83
|
|
61
|
Genome sequence of enterovirus D68 and clinical disease, Thailand.
|
Emerg Infect Dis
|
2015
|
0.83
|
|
62
|
Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B.
|
Antivir Ther
|
2007
|
0.83
|
|
63
|
Picobirnaviruses in the human respiratory tract.
|
Emerg Infect Dis
|
2012
|
0.82
|
|
64
|
Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C.
|
N Engl J Med
|
2006
|
0.82
|
|
65
|
Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection.
|
J Infect Dis
|
2003
|
0.82
|
|
66
|
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
|
Antivir Ther
|
2007
|
0.82
|
|
67
|
Identification and characterization of two novel viruses in ocular infections in reindeer.
|
PLoS One
|
2013
|
0.82
|
|
68
|
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3.
|
PLoS One
|
2012
|
0.82
|
|
69
|
Host-dependent type 1 cytokine responses driven by inactivated viruses may fail to default in the absence of IL-12 or IFN-alpha/beta.
|
J Gen Virol
|
2004
|
0.81
|
|
70
|
Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus.
|
J Gen Virol
|
2002
|
0.81
|
|
71
|
Unraveling the complexities of the interferon response during SARS-CoV infection.
|
Future Virol
|
2009
|
0.80
|
|
72
|
Genotypic anomaly in Ebola virus strains circulating in Magazine Wharf area, Freetown, Sierra Leone, 2015.
|
Euro Surveill
|
2015
|
0.79
|
|
73
|
Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells.
|
Virology
|
2006
|
0.79
|
|
74
|
[Dromedary camels and Middle East respiratory syndrome: MERS coronavirus in the 'ship of the desert'].
|
Ned Tijdschr Geneeskd
|
2014
|
0.79
|
|
75
|
Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.
|
Emerg Infect Dis
|
2019
|
0.75
|
|
76
|
Identification of protein receptors for coronaviruses by mass spectrometry.
|
Methods Mol Biol
|
2015
|
0.75
|
|
77
|
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?
|
Clin Infect Dis
|
2010
|
0.75
|
|
78
|
Presence of anti-interferon antibodies is not associated with non-response to pegylated interferon treatment in chronic hepatitis B.
|
Antivir Ther
|
2013
|
0.75
|
|
79
|
Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients.
|
Antivir Ther
|
2011
|
0.75
|
|
80
|
Immunisation with virion-loaded plasmacytoid or myeloid dendritic cells induces primary Th-1 immune responses.
|
Vaccine
|
2005
|
0.75
|